Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PLD

Wall Street Analysts' Outlook on Prologis Stock

This morning we watched Prologis drop -1.1% to a price of $113.8 per share. The Large-Cap Specialty Real Estate Investment Trust company is now trading -13.62% below its average target price of $131.75. Analysts have set target prices ranging from $119.0 to $154.0 per share for Prologis, and have given the stock an average rating of buy.

The stock has a very low short interest at 1.7%, and a short ratio of 3.0. The company's insiders own 0.29% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 95.7% of Prologis's shares being owned by this investor type.

Institutions Invested in Prologis

Date Reported Holder Percentage Shares Value
2024-09-30 Vanguard Group Inc 13% 120,915,126 $13,760,141,707
2024-09-30 Blackrock Inc. 10% 95,055,992 $10,817,372,179
2024-09-30 State Street Corporation 6% 57,413,342 $6,533,638,494
2024-09-30 JP Morgan Chase & Company 3% 29,903,350 $3,403,001,321
2024-09-30 Cohen & Steers Inc. 3% 27,449,221 $3,123,721,433
2024-09-30 Geode Capital Management, LLC 2% 20,761,980 $2,362,713,387
2024-09-30 Morgan Stanley 2% 20,056,882 $2,282,473,232
2024-09-30 Apg Asset Management US Inc. 2% 19,804,666 $2,253,771,051
2024-09-30 Bank of America Corporation 2% 19,461,081 $2,214,671,077
2024-09-30 Massachusetts Financial Services Co. 2% 16,261,892 $1,850,603,359

Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Prologis.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS